10 Overlooked Healthcare Stocks to Invest in

Page 9 of 9

1. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Holders: 57 

Teva Pharmaceutical Industries Limited (NYSE:TEVA) tops our list for being one of the overlooked stocks. It is experiencing strong momentum driven by recent product innovations and strategic initiatives. A major development is the FDA approval of AJOVY for pediatric migraine patients aged 6–17, expanding TEVA’s reach in the pediatric market. The company also reported its 10th consecutive quarter of growth, fueled by key products such as AUSTEDO, AJOVY, and UZEDY, which have seen significant sales increases in 2025.

Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s “Pivot to Growth” strategy focuses on innovation, operational efficiency, and specialty pharmaceutical expansion. The company targets a 30% operating margin by 2027 and plans to achieve approximately $700 million in net cost savings, building on $140 million in annual run-rate savings already realized in 2025. This transformation supports both its generics foundation and the growth of specialty medicines.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is actively advancing its R&D pipeline, including duvakitug, a Phase 3 candidate for autoimmune diseases like ulcerative colitis and Crohn’s disease. This focus on innovative specialty therapies, alongside strong generics and biosimilars performance, positions Teva for long-term growth.

While we acknowledge the potential of TEVA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TEVA and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9